Literature DB >> 29754820

Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer.

Allen W Zhang1, Andrew McPherson2, Katy Milne3, David R Kroeger3, Phineas T Hamilton3, Alex Miranda3, Tyler Funnell4, Nicole Little3, Camila P E de Souza5, Sonya Laan3, Stacey LeDoux3, Dawn R Cochrane2, Jamie L P Lim2, Winnie Yang2, Andrew Roth6, Maia A Smith2, Julie Ho7, Kane Tse8, Thomas Zeng8, Inna Shlafman8, Michael R Mayo8, Richard Moore8, Henrik Failmezger9, Andreas Heindl9, Yi Kan Wang2, Ali Bashashati2, Diljot S Grewal2, Scott D Brown10, Daniel Lai2, Adrian N C Wan2, Cydney B Nielsen11, Curtis Huebner2, Basile Tessier-Cloutier11, Michael S Anglesio12, Alexandre Bouchard-Côté13, Yinyin Yuan9, Wyeth W Wasserman14, C Blake Gilks11, Anthony N Karnezis11, Samuel Aparicio5, Jessica N McAlpine15, David G Huntsman5, Robert A Holt8, Brad H Nelson16, Sohrab P Shah17.   

Abstract

High-grade serous ovarian cancer (HGSC) exhibits extensive malignant clonal diversity with widespread but non-random patterns of disease dissemination. We investigated whether local immune microenvironment factors shape tumor progression properties at the interface of tumor-infiltrating lymphocytes (TILs) and cancer cells. Through multi-region study of 212 samples from 38 patients with whole-genome sequencing, immunohistochemistry, histologic image analysis, gene expression profiling, and T and B cell receptor sequencing, we identified three immunologic subtypes across samples and extensive within-patient diversity. Epithelial CD8+ TILs negatively associated with malignant diversity, reflecting immunological pruning of tumor clones inferred by neoantigen depletion, HLA I loss of heterozygosity, and spatial tracking between T cell and tumor clones. In addition, combinatorial prognostic effects of mutational processes and immune properties were observed, illuminating how specific genomic aberration types associate with immune response and impact survival. We conclude that within-patient spatial immune microenvironment variation shapes intraperitoneal malignant spread, provoking new evolutionary perspectives on HGSC clonal dispersion.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HGSC; HLA; clonal evolution; clone; foldback inversion; high-grade serous ovarian cancer; human leukocyte antigen; immunoediting; intratumoral heterogeneity; metastatic; mutation signature; tumor-infiltrating lymphocyte

Mesh:

Substances:

Year:  2018        PMID: 29754820     DOI: 10.1016/j.cell.2018.03.073

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  106 in total

Review 1.  Characterizing the ecological and evolutionary dynamics of cancer.

Authors:  Nastaran Zahir; Ruping Sun; Daniel Gallahan; Robert A Gatenby; Christina Curtis
Journal:  Nat Genet       Date:  2020-07-27       Impact factor: 38.330

Review 2.  Genetic and non-genetic clonal diversity in cancer evolution.

Authors:  James R M Black; Nicholas McGranahan
Journal:  Nat Rev Cancer       Date:  2021-03-16       Impact factor: 60.716

Review 3.  The Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment.

Authors:  Samuel F Bakhoum; Lewis C Cantley
Journal:  Cell       Date:  2018-09-06       Impact factor: 41.582

4.  Infiltration of CD8+ T cells into tumor cell clusters in triple-negative breast cancer.

Authors:  Xuefei Li; Tina Gruosso; Dongmei Zuo; Atilla Omeroglu; Sarkis Meterissian; Marie-Christine Guiot; Adam Salazar; Morag Park; Herbert Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-07       Impact factor: 11.205

5.  A single-cell landscape of high-grade serous ovarian cancer.

Authors:  Benjamin Izar; Itay Tirosh; Elizabeth H Stover; Isaac Wakiro; Michael S Cuoco; Idan Alter; Christopher Rodman; Rachel Leeson; Mei-Ju Su; Parin Shah; Marcin Iwanicki; Sarah R Walker; Abhay Kanodia; Johannes C Melms; Shaolin Mei; Jia-Ren Lin; Caroline B M Porter; Michal Slyper; Julia Waldman; Livnat Jerby-Arnon; Orr Ashenberg; Titus J Brinker; Caitlin Mills; Meri Rogava; Sébastien Vigneau; Peter K Sorger; Levi A Garraway; Panagiotis A Konstantinopoulos; Joyce F Liu; Ursula Matulonis; Bruce E Johnson; Orit Rozenblatt-Rosen; Asaf Rotem; Aviv Regev
Journal:  Nat Med       Date:  2020-06-22       Impact factor: 53.440

6.  Neoantigens in Ovarian Cancer: Embarrassment of Riches or Needles in a Haystack?

Authors:  Iain A McNeish
Journal:  Clin Cancer Res       Date:  2018-07-06       Impact factor: 12.531

Review 7.  Extrachromosomal oncogene amplification in tumour pathogenesis and evolution.

Authors:  Roel G W Verhaak; Vineet Bafna; Paul S Mischel
Journal:  Nat Rev Cancer       Date:  2019-05       Impact factor: 60.716

8.  PhyDOSE: Design of follow-up single-cell sequencing experiments of tumors.

Authors:  Leah L Weber; Nuraini Aguse; Nicholas Chia; Mohammed El-Kebir
Journal:  PLoS Comput Biol       Date:  2020-10-01       Impact factor: 4.475

9.  Multisite Tumor Sampling Reveals Extensive Heterogeneity of Tumor and Host Immune Response in Ovarian Cancer.

Authors:  Sotirios Lakis; Vassiliki Kotoula; Georgia-Angeliki Koliou; Ioannis Efstratiou; Sofia Chrisafi; Alexios Papanikolaou; Pantelis Zebekakis; George Fountzilas
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

Review 10.  Tumour evolution in hepatocellular carcinoma.

Authors:  Amanda J Craig; Johann von Felden; Teresa Garcia-Lezana; Samantha Sarcognato; Augusto Villanueva
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-12-02       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.